BACKGROUND AND AIMS
Hypertension is a common attributable cause of chronic kidney disease (CKD). Mineralocorticoid receptor overactivation can lead to hypertension and contributes to CKD progression. In FIND-CKD, finerenone reduced kidney function decline in participants with CKD without diabetes. This prespecified FIN...
H. Heerspink, Jelle M. Beernink, R. Agarwal et al.· European Heart Journal· 0 citations
ABSTRACT Introduction Chronic kidney disease (CKD) affects ~30–40% of people living with type-1 diabetes (T1D) and remains a major driver of cardiovascular morbidity, kidney-failure, and premature mortality. Despite advances in diabetes-technologies, kidney-protective pharmacotherapy in T1D has remained largely unchang...
Marcel H. A. Muskiet, D. Cherney· Expert Review of Endocrinolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.